Literature DB >> 7155995

Local hyperthermia for treatment of carcinoma of the prostate: a preliminary report.

A Yerushalmi, C Servadio, Z Leib, Y Fishelovitz, E Rokowsky, J A Stein.   

Abstract

Following extensive experiments on animals, we have concluded a study on the treatment of 15 patients with prostatic carcinoma using localized deep microwave hyperthermia (LDMWH; 2.45 GHZ), either alone or in combination with radiotherapy or hormonal therapy. The results of this pilot trial were encouraging and are herewith presented. A total of 146 LDMWH treatments were given. All patients tolerated the treatments well, and there were no complications; the condition of the rectal mucosa was checked routinely by rectoscopy. A pronounced and rapid subjective and objective response was recorded in all cases, as noted by reduction in tumor size, regression of ureteral or urethral obstruction, disappearance of pelvic pain and improvement in well being. LDMWH was effective by itself and appeared to potentiate the effects of radiotherapy or hormonal therapy. Although LDMWH seems to be a promising and safe new method of treatment of prostatic cancer, either alone or in combination with other accepted forms of therapy, more controlled studies, which are at present underway, are needed to draw more definite conclusions.

Entities:  

Mesh:

Year:  1982        PMID: 7155995     DOI: 10.1002/pros.2990030612

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

Review 1.  Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.

Authors:  Sunil Krishnan; Parmeswaran Diagaradjane; Sang Hyun Cho
Journal:  Int J Hyperthermia       Date:  2010-09-21       Impact factor: 3.914

Review 2.  Treatment options for benign prostatic hyperplasia.

Authors:  A J Portis; D R Mador
Journal:  Can Fam Physician       Date:  1997-08       Impact factor: 3.275

Review 3.  [Local treatment of prostate cancer using thermal-ablative energy].

Authors:  R Muschter
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

Review 4.  Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy.

Authors:  Evan R Eisenberg; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

5.  Transferrin as a thermosensitizer in radiofrequency hyperthermia for cancer treatment.

Authors:  Hea-Jong Chung; Heui-Kwan Lee; Ki Beom Kwon; Hyeon-Jin Kim; Seong-Tshool Hong
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.